HLA-A and small cell lung carcinoma: At the single-target level, SCLC immunopeptidomics identified an HLA-A*02:01–restricted epitope from ATAD2 (YSDDDVPSV) with robust T-cell recognition, offering a subtype-specific, shared target for adoptive and vaccine strategies (145).